We are monitoring the impact of COVID-19 on MEA Peptic Ulcer Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2021
ID: 12218
Share on
Share on

Middle East & Africa Peptic Ulcer Drugs Market Research Report - Segmented By drugs type, ulcer, and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: October, 2021
ID: 12218
Pages: 100

MEA Peptic ulcer drugs Market Size (2021 to 2026)

The Middle East & Africa Peptic ulcer drugs Market was worth USD 0.26 billion in 2021 and is estimated to be growing at a CAGR of 0.99%, to reach USD 0.27 billion by 2026.

A peptic ulcer is a breakage in the inner surface of the stomach or the upper part of the intestine in the gastrointestinal tract. Ulcers form when the protective wall of the intestine or stomach is broken.

The MEA peptic ulcer drug market is expected to grow at a gradual rate in the coming years, due to increasing patient awareness of the easy availability of effective drugs for peptic ulcers. In addition, the increasing preference of patients for the consumption of drugs due to increased effectiveness should encourage the drug manufacturers to develop new drugs in the years to come. Products with lesser side effects and research and developments especially in medical institutions and hospitals will support the market in the MEA region.

There is an increasing rate of chronic disease patients such as Irritable Bowel Syndrome, cancer, muscular-skeletal diseases which required long-term and heavy use of pain-relieving medications. Factors such as the higher cost of alternative treatment to tackle peptic ulcers, improvements in healthcare infrastructure, and increased funding by government agencies of the healthcare system are driving the growth of the drug market for peptic ulcer disease in the MEA region. Increasing in the number of patients developing quadruple bismuth therapy, the change in lifestyle and diet, the growing inclination towards generics are expected to boost the MEA market and provide lucrative opportunities for the major players in the years to come.

However, Factors such as the increased adverse effects of proton pump inhibitors, expiration of patents for various drugs due to their effectiveness are expected to restraint the MEA market growth rate.

This research report on the MEA peptic ulcer drugs market has been segmented and sub-segmented into the following categories:

By Drug Type:

  • Proton Pump Inhibitors (PPIs)
  • Anti-Histamines
  • H2 Antagonists
  • Antacids
  • Antibiotics
  • Others

By Ulcer Type:

  • Gastric Ulcers
  • Duodenal Ulcer
  • Esophageal Ulcer

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA peptic ulcer drugs market is leading and this is analyzed to remain dominant throughout the forecast period. The growing incidence of people with peptic ulcers is one of the key factors that should drive the development of the Middle East market in the years to come. The growing incidence of peptic ulcers is encouraging companies to market and produce peptic ulcer drugs in MEA, particularly in Saudi Arabia, UAE, and Qatar.

In addition, Saudi Arabia and the UAE will achieve a substantial share of the MEA market in the near future. A large number of patents that may expire, allowing the entry of generics, are expected to drive MEA market growth. In contrast, emerging economies in African region in the Middle East and Asia are expected to experience good growth during the forecast period. The increasing demand for peptic ulcer drugs due to poor hygiene and disinfection leading to H. pylori among the inhabitants of these regions is the key factor that is expected to boost the market for peptic ulcer drugs market over the next few years.

Saudi Arabia will be the largest revenue-generating regional market for peptic ulcer drugs due to more affected people, improved diagnostic techniques, high healthcare awareness, and increased awareness of peptic ulcer disease. Other regions such as Kuwait, Bahrain, Oman, and Egypt are expected to gather good market revenues during the projected period. South Africa will grow at a good CAGR during the forecast period owing to the population, developing economic conditions, and improving health infrastructure in the region.

KEY MARKET PLAYERS:

Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc., Helicure AB and Eumedica Pharmaceuticals are some of the companies currently dominating the MEA peptic ulcer drugs market and profiled in this report.

            1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 The MEA Peptic Ulcer Drugs Market - By Drug Type:                     

                        6.1.1  Proton Pump Inhibitors (PPIs) 

                        6.1.2  Anti-Histamines

                        6.1.3    H2 Antagonists           

                        6.1.4  Antacids

                        6.1.5  Antibiotics        

                        6.1.6 Others   

                        6.1.7 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.8 Y-o-Y Growth Rate Analysis      

                        6.1.9 Market Attractiveness Index    

            6.2 The MEA Peptic Ulcer Drugs Market -By Ulcer Type:                      

                        6.2.1 Gastric Ulcers    

                        6.2.2 Duodenal Ulcer 

                        6.2.3  Esophageal Ulcer         

                        6.2.4 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.5 Y-o-Y Growth Rate Analysis      

                        6.2.6 Market Attractiveness Index    

7. Geographical Landscape                            

            7.1 Middle East and Africa                 

                        7.1.1 By Country        

                                    7.1.1.1 Middle East

                                    7.1.1.2 Africa

                        7.1.2 By Drug Type:   

                        7.1.3 By Ulcer Type:   

8. Key Player Analysis                        

            8.1 Novartis AG                      

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 Daiichi Sankyo Company Limited            

            8.3 Acetelion Ltd                    

            8.4 Boehringer Ingelheim                  

            8.5 Sanofi S.A.            

            8.6 Astra Zeneca                    

            8.7 Ranbaxy Laboratories Limited, Inc.                     

            8.8 Takeda Pharmaceuticals Company Limited                    

            8.9 Pfizer Inc.             

            8.10 Helicure AB                    

            8.11 Eumedica Pharmaceuticals                    

9. Market Outlook & Investment Opportunities                               

10. Appendix                          

            List of Tables              

            List of Figures        

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 
  • The segment-level analysis in terms of drugs type, ulcer type, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.
  1. Middle East and Africa peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  2. Middle East and Africa  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  3. Middle East and Africa Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  4. Middle East and Africa H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  5. Middle East and Africa   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  6. Middle East and Africa Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  7. Middle East and Africa Others Market By Region, From 2021 to 2026 ( USD Billion )

  8. Middle East and Africa peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  9. Middle East and Africa   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  10. Middle East and Africa Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  11. Middle East and Africa Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  12. Middle East peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  13. Middle East peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  14. Africa peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  15. Africa peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample